Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Differential expression of synaptic markers regulated during neurodevelopment in a rat model of schizophrenia-like behavior

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Authors' response: Association between IBD and Parkinson's disease: seek and you shall find?

    Publikation: Bidrag til tidsskriftKommentar/debatForskning

  4. Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ignasi Oliveras
  • Ana Sánchez-González
  • Daniel Sampedro-Viana
  • Maria Antonietta Piludu
  • Cristóbal Río-Alamos
  • Osvaldo Giorgi
  • Maria G Corda
  • Susana Aznar
  • Javier González-Maeso
  • Cristina Gerbolés
  • Gloria Blázquez
  • Toni Cañete
  • Adolf Tobeña
  • Alberto Fernández-Teruel
Vis graf over relationer
Animal models with predictive and construct validity are necessary for developing novel and efficient therapeutics for psychiatric disorders.

We have carried out a pharmacological characterization of the Roman high- (RHA-I) and low-avoidance (RLA-I) rat strains with different acutely administered propsychotic (DOI, MK-801) and antipsychotic drugs (haloperidol, clozapine), as well as apomorphine, on prepulse inhibition (PPI) of startle and locomotor activity (activity cages).

RHA-I rats display a consistent deficit of PPI compared with RLA-I rats. The typical antipsychotic haloperidol (dopamine D2 receptor antagonist) reversed the PPI deficit characteristic of RHA-I rats (in particular at 65 and 70 dB prepulse intensities) and reduced locomotion in both strains. The atypical antipsychotic clozapine (serotonin/dopamine receptor antagonist) did not affect PPI in either strain, but decreased locomotion in a dose-dependent manner in both rat strains. The mixed dopamine D1/D2 agonist, apomorphine, at the dose of 0.05 mg/kg, decreased PPI in RHA-I, but not RLA-I rats. The hallucinogen drug DOI (5-HT2A agonist; 0.1–1.0 mg/kg) disrupted PPI in RLA-I rats in a dose-dependent manner at the 70 dB prepulse intensity, while in RHA-I rats, only the 0.5 mg/kg dose impaired PPI at the 80 dB prepulse intensity. DOI slightly decreased locomotion in both strains. Finally, clozapine attenuated the PPI impairment induced by the NMDA receptor antagonist MK-801 only in RLA-I rats.

These results add experimental evidence to the view that RHA-I rats represent a model with predictive and construct validity of some dopamine and 5-HT2A receptor-related features of schizophrenia.
Udgave nummer6
Sider (fra-til)957-975
Antal sider19
StatusUdgivet - mar. 2017

ID: 52335338